Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals (Q4628378)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals |
scientific article; zbMATH DE number 7035513
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals |
scientific article; zbMATH DE number 7035513 |
Statements
Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals (English)
0 references
13 March 2019
0 references
continual reassessment method
0 references
dose-finding
0 references
dose-limiting toxicity
0 references
maximum tolerated dose
0 references
nonparametric optimal design
0 references
